Placental circulating T cells expressing CD16 in combination with trastuzumab demonstrate robust anti-tumor antibody-dependent cellular cytotoxicity (ADCC) against gastric cancer

Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca

PT-CD16VS - Celularity

Herceptin (trastuzumab) - Roche

K. Karasiewicz-Mendez; J. Gleason; K. Tess; M. Djedaini; S. Lin; C. Huang; S. He; R. Hariri; A. Kilcoyne

Mar 6, 2024